Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Ascorbic Acid in Severe Sepsis
NCT02734147Phase 2Terminated
- Sponsor
- ChristianaCare
- Start
- Apr 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in sepsis, sponsored by ChristianaCare. Started Apr 2016; status: terminated.
02
Drugs
ascorbic acid
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02734147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734147.